✦ LIBER ✦

Lipid lowering therapy and coronary heart disease risk assessment in general practice

✍ Scribed by A. Makin; G.Y.H. Lip

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Global risk assessment for lipid therapy

✍ Caitlin M. Nass; Stephen D. Wiviott; Jerilyn K. Allen; Wendy S. Post; Roger S. B 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 384 KB

Lipid assessment, metabolic syndrome and

✍ Benoit J. Arsenault; Jean-Pierre Després; Erik S. G. Stroes; Nicholas J. Wareham 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Lipid-lowering therapy does not increase

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Benefits of lipid-lowering agents in str

✍ Stanley G. Rockson 📂 Article 📅 2000 🏛 Current Science Inc. 🌐 English ⚖ 270 KB

The effect of lipid-lowering therapy on

✍ Vulic, D.; Keric, Lj.; Vulic, B.; Bajic, S.; Pavic, Z. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Screening people with diabetes for risk

✍ Shaper, AG ;Perry, IJ 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB